| Net Cash Provided by (Used in) Operating Activities |
$20,399,000 |
USD |
83% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$51,328,000 |
USD |
-70% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
150,000,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
89,834,849 |
shares |
1.6% |
Q4 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$30,929,000 |
USD |
-44% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$41,959,000 |
USD |
-46% |
Q4 2025 |
FY 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$32,924,000 |
USD |
85% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Gross |
$31,701,000 |
USD |
20% |
Q4 2025 |
FY 2025 |
| Deferred Income Tax Expense (Benefit) |
$18,331,000 |
USD |
-0.6% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$3,233,000 |
USD |
-49% |
Q4 2025 |
FY 2025 |
| Deferred Federal Income Tax Expense (Benefit) |
$23,363,000 |
USD |
46% |
Q1 2025 |
Q1 2025 |
| Current Income Tax Expense (Benefit) |
$8,735,000 |
USD |
24% |
Q1 2025 |
Q1 2025 |
| Additional Paid in Capital |
$2,457,660,000 |
USD |
2.6% |
Q4 2025 |
FY 2025 |
| Current State and Local Tax Expense (Benefit) |
$1,769,000 |
USD |
-22% |
Q1 2025 |
Q1 2025 |
| Current Federal Tax Expense (Benefit) |
$696,000 |
USD |
-50% |
Q1 2025 |
Q1 2025 |
| Share-based Payment Arrangement, Expense |
$21,440,000 |
USD |
14% |
Q4 2025 |
FY 2025 |
| Deferred State and Local Income Tax Expense (Benefit) |
$5,032,000 |
USD |
-308% |
Q1 2025 |
Q1 2025 |
| Interest Expense |
$104,354,000 |
USD |
21% |
Q1 2024 |
Q1 2024 |